VENTAVIS sol inhal 20 mcg/2ml 2 ml amp 30 pce
7680562130020
CH-56213
B01AC11
02.07.1.
Reimbursement limitations:
VENTAVIS
Hypertension pulmonaire chez les patients avec NYHA III et IV (définition d'après la New York …
1 / 3
google
Details
- Product number
- 5621301
- CPT
- -
- Packaging group
- 30
- Unit
- Ampulle(n)
- Composition
- iloprostum 10 µg ut iloprostum trometamolum, trometamolum, ethanolum 0.75 mg, natrii chloridum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Ventavis, Lösung für einen Vernebler
Lösung
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.75 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 890.25
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2008
Authorization holder
Bayer (Schweiz) AG
8045 Zürich
Authorization information
- Swissmedic authorization number
- 56213
- Drug name
- Ventavis, Lösung für einen Vernebler
- Galenic form
- LSVE
- ATC Code
- B01AC11
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 22/11/2005
- Authorization expiration date
- 31/12/9999
- IT number
- 02.07.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VENTAVIS sol inhal 20 mcg/2ml 2 ml amp 30 pce
- Description (DE)
- VENTAVIS Inhal Lös 20 mcg/2ml 2 ml Amp 30 Stk
- Market launch
- 22/11/2005
- Narcotic (BTM)
- No